-
1دورية أكاديمية
المؤلفون: Gertz M, Abonour R, Gibbs SN, Finkel M, Landau H, Lentzsch S, Lin G, Mahindra A, Quock T, Rosenbaum C, Rosenzweig M, Sidana S, Tuchman SA, Witteles R, Yermilov I, Broder MS
المصدر: ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 673-680 (2023)
مصطلحات موضوعية: consensus, hematology, outcomes research, mayo stage, cardiac failure, Medicine (General), R5-920, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Dupuis MM, Tuchman SA
المصدر: OncoTargets and Therapy, Vol Volume 9, Pp 7583-7590 (2016)
مصطلحات موضوعية: multiple myeloma, non-secretory, immunoglobulin, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3
المؤلفون: Prytula, Agnieszka, Iijima, K, Kamei, K, Geary, D, Gottlich, E, Majeed, A, Taylor, M, Marks, S, Tuchman, SA, Camilla, R, Ognjanovic, M, Filler, G, Smith, G, Tullus, K
المساهمون: Pediatrics
المصدر: Pediatric Nephrology, 25, 461-468. Springer
-
4
المؤلفون: Rao, AV, Valk, Peter, Metzeler, KH, Acharya, CR, Tuchman, SA, Stevenson, MM, Rizzieri, DA, Delwel, Ruud, Buske, C, Bohlander, SK, Potti, A, Löwenberg, Bob
المساهمون: Hematology
المصدر: Journal of Clinical Oncology, 27(33), 5580-5586. American Society of Clinical Oncology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::f6db13c4b1f47c9d85ce05acac94070c
https://pure.eur.nl/en/publications/ef1e4493-a50f-486b-a62b-f1a06fbacca7 -
5دورية أكاديمية
المؤلفون: Anguiano A, Tuchman SA, Acharya C, Salter K, Gasparetto C, Zhan F, Dhodapkar M, Nevins J, Barlogie B, Shaughnessy JD Jr, Potti A, Anguiano, Ariel, Tuchman, Sascha A, Acharya, Chaitanya, Salter, Kelly, Gasparetto, Cristina, Zhan, Fenghuang, Dhodapkar, Madhav, Nevins, Joseph, Barlogie, Bart
المصدر: Journal of Clinical Oncology; 9/1/2009, Vol. 27 Issue 25, p4197-4203, 7p
-
6دورية أكاديمية
المؤلفون: Voorhees PM; Levine Cancer Institute, Atrium Health Wake Forest Baptist, Charlotte, North Carolina, United States., Suman V; Alliance Statistics and Data Center, United States., Efebera YA; OhioHealth, Columbus, Ohio, United States., Raje N; Massachusetts General Hospital, Boston, Massachusetts, United States., Tuchman SA; Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States., Rodriguez C; Icahn School of Medicine at Mount Sinai, New York, New York, United States., Laubach JP; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Bova-Solem M; Alliance Statistics and Data Center, United States., Carlisle D; Alliance for Clinical Trials in Oncology, Chicago, Illinois, United States., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, New York, United States., McCarthy PL; Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States., Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States.
المصدر: Blood advances [Blood Adv] 2024 Jul 26. Date of Electronic Publication: 2024 Jul 26.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
-
7دورية أكاديمية
المؤلفون: LeBlanc MR; University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, North Carolina, USA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA. Electronic address: matthew_leblanc@unc.edu., Zhou X; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Baggett CD; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Tuchman SA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Jensen CE; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Lichtman EI; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Rubinstein SM; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Apr 19. Date of Electronic Publication: 2024 Apr 19.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Jensen CE; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: christopher.jensen@unchealth.unc.edu., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: allison_deal@med.unc.edu., Nyrop KA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA. Electronic address: kirsten_nyrop@med.unc.edu., Logan M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: mayal99@live.unc.edu., Mangieri NJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: nicholas_mangieri@med.unc.edu., Strayhorn MD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: dell_strayhorn@med.unc.edu., Miller J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: jordan.miller@unchealth.unc.edu., Muss HB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA. Electronic address: hyman_muss@med.unc.edu., Lichtman EI; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: eben_lichtman@med.unc.edu., Rubinstein SM; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: samuel_rubinstein@med.unc.edu., Tuchman SA; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Physicians Office Building, CB# 7305, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, Chapel Hill, NC 27599, USA. Electronic address: sascha_tuchman@med.unc.edu.
المصدر: Journal of geriatric oncology [J Geriatr Oncol] 2024 Mar; Vol. 15 (2), pp. 101680. Date of Electronic Publication: 2023 Dec 16.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Multiple Myeloma*/therapy , Neoplasms*/therapy, Aged ; Humans ; Geriatric Assessment ; Feasibility Studies ; Medical Oncology ; Mental Health
-
9دورية أكاديمية
المؤلفون: Schiller GJ; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. Electronic address: gschiller@mednet.ucla.edu., Lipe BC; University of Rochester, Rochester, NY., Bahlis NJ; Charbonneau Cancer Research Institute, Calgary, AB, Canada; Clinical Research Unit, Tom Baker Cancer Center, Calgary, AB, Canada., Tuchman SA; University of North Carolina, Chapel Hill, NC., Bensinger WI; Swedish Cancer Institute, Seattle, WA., Sutherland HJ; Vancouver General Hospital, Vancouver, BC, Canada., Lentzsch S; Multiple Myeloma and Amyloidosis Service, Columbia University, New York, NY., Baljevic M; Vanderbilt University Medical Center, Nashville, TN., White D; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada., Kotb R; CancerCare Manitoba, Winnipeg, MB, Canada., Chen CI; Princess Margaret Cancer Centre, Toronto, ON, Canada., Rossi A; Weill Cornell Medicine, New York, NY., Biran N; Hackensack Meridian Health, Hackensack University Medical Center, Hackensack, NJ., LeBlanc R; Maisonneuve-Rosemont Hospital, University of Montreal, QC, Canada., Grosicki S; Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland., Martelli M; Department of Cellular Biotechnology and Hematology, Hematology Center, Umberto I Polyclinic of Rome, Rome, Italy., Gunsilius E; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria., Špička I; First Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic., Stevens DA; Norton Cancer Institute, St. Matthews Campus, Louisville, KY., Facon T; Department of Hematology (Maladies du sang), Hôpital Huriez, CHU, Lille, France., Mesa MG; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain., Zhang C; Karyopharm Therapeutics Inc., Newton, MA., Van Domelen DR; Karyopharm Therapeutics Inc., Newton, MA., Bentur OS; Karyopharm Therapeutics Inc., Newton, MA., Gasparetto C; Duke University Cancer Center, Durham, NC.
المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Sep; Vol. 23 (9), pp. e286-e296.e4. Date of Electronic Publication: 2023 Jun 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
-
10دورية أكاديمية
المؤلفون: Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA. yubin.kang@duke.edu., Sundaramoorthy P; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Feinberg D; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Fan S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Long G; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Sellars E; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Garrett A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Suite 5000, Durham, NC, DUMC 396127710, USA., Tuchman SA; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Reeves BN; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Li Z; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA., Liu B; Division of Hematology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Ogretmen B; Department of Biochemistry and Molecular Biology, and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Maines L; Apogee Biotechnology Corporation, Hummelstown, PA, USA., Ben-Yair VK; RedHill Biopharma, Tel Aviv, Israel., Smith C; Apogee Biotechnology Corporation, Hummelstown, PA, USA., Plasse T; RedHill Biopharma, Tel Aviv, Israel.
المصدر: Annals of hematology [Ann Hematol] 2023 Feb; Vol. 102 (2), pp. 369-383. Date of Electronic Publication: 2022 Dec 03.
نوع المنشور: Clinical Trial, Phase I; Journal Article
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE